Chempass Company
ChemPass was founded to develop AI technologies and software for the design of novel small organic molecules and scaffolds. ChemPass' technologies utilize synthetic artificial intelligence for template design, in silico reaction planning and evaluation, a chemistry know-how database and several other custom solutions.
%20.jpg)
Technology:
Drug Design
Number Of Exists:
N/A
Funding Status:
Seed
Investor Type:
N/A
Industry:
Drug Discovery
Headquarters:
Budapest, Budapest, Hungary
Investment Stage:
N/A
Employee Number:
Undisclosed
Founded Date:
2016